The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors associated with short-term survival (STS) in advanced pancreatic cancer (APC): A multicenter analysis from the CHORD consortium.
 
Sakshi Mehta
Employment - Sunnybrook Health Sciences Centre (I); Sunnybrook Health Sciences Centre (I); Sunnybrook Health Sciences Centre (I); Sunnybrook Health Sciences Centre (I)
 
Miguel Cardoso
No Relationships to Disclose
 
Christina Kim
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst)
 
Dawn Elizabeth Armstrong
Honoraria - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Celgene; Celgene; Celgene; Celgene
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen
 
Ravi Ramjeesingh
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Roche; Roche; Roche; Roche; Shire; Shire; Shire; Shire
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc
 
Daniel John Renouf
Honoraria - Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst)
 
Shahid Ahmed
No Relationships to Disclose
 
Yoo-Joung Ko
Honoraria - Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly
Research Funding - Celgene; Celgene; Celgene; Celgene
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene
 
Mohammed Harb
No Relationships to Disclose
 
Shiying Kong
No Relationships to Disclose
 
Winson Y. Cheung
No Relationships to Disclose
 
Brandon M. Meyers
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Sillajen (Inst); Sillajen (Inst); Sillajen (Inst); Sillajen (Inst)
Travel, Accommodations, Expenses - Eisai; Eisai; Eisai; Eisai